<DOC>
	<DOCNO>NCT01291329</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy intracoronary human umbilical Wharton 's jelly-derived mesenchymal stem cell ( WJ-MSC ) transfer patient ST-segment elevation acute myocardial infarction .</brief_summary>
	<brief_title>Intracoronary Human Wharton 's Jelly- Derived Mesenchymal Stem Cells ( WJ-MSCs ) Transfer Patients With Acute Myocardial Infarction ( AMI )</brief_title>
	<detailed_description>It demonstrate MSCs potential differentiate cardiomyocytes vitro vivo . Several clinical trial perform use autologous bone marrow-derived MSCs , result trial unsatisfactory low number MSCs old patient coronary heart disease . WJ-MSCs human umbilical cord matrix epiblastic origin contain human embryonic stem cell ( hESC ) human mesenchymal stem cell marker appear number important advantage : raise ethical issue , widely multipotent , tumorigenic , immunogenetic . Because short population double time rapidly scale large number . We perform double-blind , placebo-controlled , multicenter trial , randomly assign 160 patient acute ST-segment elevation myocardial infarction receive intracoronary infusion WJ-MSCs placebo medium infarct artery 4-7 day successful reperfusion therapy .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>1 . Patients least 18 year age； 2 . Patients 1st acute STelevation myocardial infarction ( AMI ) undergo successful primary percutaneous coronary intervention ( PCI ) thrombolysis myocardial infarction ( TIMI ) flow grade 3 , substantial residual leave ventricular regional wallmotion abnormality measure 2D echocardiography . 3 . No contraindication undergo celltherapy procedure within 1 week AMI PCI . 4 . Hemodynamic stability—defined requirement intraaortic balloon pump inotropic bloodpressure support medication . 5 . Consent protocol agree comply followup visit study . 1 . Presence cardiogenic shock ( define systolic blood pressure &lt; 80 mmHg require intravenous pressor intraaortic balloon counterpulsation ) ; 2 . Major bleed require blood transfusion acute reperfusion treatment ; 3 . A history leucopenia ; 4 . Thrombocytopenia ; 5 . Hepatic renal dysfunction ; 6 . Evidence malignant disease ; 7 . Unwillingness participate ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>stem cell</keyword>
	<keyword>acute ST-Elevation Myocardial Infarction</keyword>
</DOC>